Members of the Jamaica Health Ministry and the University of the West Indies met with the University of Buffalo (UB) and SUNY faculty, to begin exploring ways to share research and clinical findings to help both countries. The meeting was focused on instituting a new center to study infectious diseases and engage in team science and collaborative research to achieve sustainable health in the Caribbean region. Though the center will be based in Jamaica, it will also have a presence in Buffalo, possibly at the UB Center of Excellence in Bioinformatics & Life Sciences.
Reference Link: http://www.buffalo.edu/news/releases/2019/04/012.html
The East African Science and Technology Commission or EASTECO has launched a local journal to promote research in science, technology and innovation. This is a step forward to improve sharing knowledge among the scientific community. The most interesting thing is that this is the first journal of its kind in the region. It is funded by six EAC states. EASTECO’s executive sectary, Gertrude Ngabirano said they aim new information which can be used to address issues disturbing the region. It will also help come up with evidence-based policies.
Reference Link: https://www.newvision.co.ug/new_vision/news/1497716/eac-launch-regional-science-journal-promote-research-innovation
The New England Journal of Medicine or NEJM thinks open-access is not a good idea. An editorial published by Charlotte Haug, one of the correspondents of NEJM reports that the “experiment” has failed, and free access to scientific publications hasn’t delivered on its promises. NEJM is particularly concerned about “Plan S”, a plan in Europe that suggests that all scientists whose work is funded by the community be required to publish their results in open-access venues. Plan S is due to take upshot in 2020.
Reference Link: https://www.forbes.com/sites/stevensalzberg/2019/04/01/nejm-says-open-access-publishing-has-failed-right/#59541d546a44
Future Drug Discovery is a peer-reviewed, open access journal covering the latest breakthrough science in drug discovery, research & development. Future Drug Discovery aims to harness high failure rates, presenting new advances and discussing their applications and translation in an openly accessible format, and providing a forum for discussing the field at large. It will be a quarterly publication publishing case histories, methodologies, original research, reviews and opinion articles covering the entire drug discovery pipeline, plus topics of interest to the drug discovery community. A comprehensive list of topics can be found at the journal webpage.
Reference Link: https://www.eurekalert.org/pub_releases/2019-03/fsg-fsg032619.php
According to a study, scientists from pharmaceutical trade publish a higher fraction of their papers open access than academics who aren’t in industry. The open-access papers published by 23 large drug companies, such as Pfizer and Roche has overtaken the quantity of liberally available papers published most prominently in medicine-related fields.“It seems like big pharma has a notable niche in open access,” says Kyle Siler, a social scientist at Utrecht University in the Netherlands.
As a leader in the universal movement toward open access to publicly funded research, the University of California terminated its further subscriptions with Elsevier, the world’s largest scientific publisher. Despite months of bond negotiations, Elsevier was reluctant to meet UC’s key goal: acquiring universal open access to UC research to enable users to view it excluding any charges- as well as to restrain the rising costs associated with for-profit journals. Under Elsevier’s new proposed terms, the publisher would have charged UC authors large publication fees on top of the university’s multi-million dollar subscription, subsequently increasing the cost to the University and greater profits for Elsevier.
Reference link: https://news.berkeley.edu/2019/02/28/why-uc-split-with-publishing-giant-elsevier/
New research carried out by the High-Performance Networks Research Group at the University of Bristol’s Smart Internet Lab, has validated a groundbreaking solution for the concerns on security susceptibility of 5G networks which are anticipated to transform the telecommunication industry. The findings were presented on 7 March at a highly prestigious post-deadline paper in the Optical Fibre Communication Conference, San Diego, USA. The proposed solution will enable 5G network operators to offer ultimately secure 5G services while assuring ultra-low-latency and high-bandwidth communications. This is due to the unique blend of quantum and infrastructure virtualization technologies.
Reference link: http://bristol.ac.uk/news/2019/march/quantum-cryptography.html
Researchers of the Nigeria Centre for Disease Control (NCDC) in Ahuja, and its director general, Chikwe Ihekweazu are building strategies to fight infectious diseases that are more often than not outbreaks in Africa. NCDC’s approach to disease research in Africa is self-assured and revolutionary. The agency is assisting to shape the priorities of international scientists who wish to conduct research in Nigeria. Nigeria is vital, as the nation is massive and the country is poked with outbreaks like Ebola that could crash Africa’s economy and spread worldwide. Supporting African-led research is good for science, good for Africa and good for the entire world.
Reference link: https://www.nature.com/articles/d41586-019-00612-0
Industry supervisors envisage Japan to be the second fastest growing mature marketplace for solid dose drugs in 2019 followed by the United States. The findings represent a considerable year-on-year improvement in outlook for pharma in Japan with expected growth of solid dose formulations improving by more than 10% with generic drug classes highlighted Significantly, it ranks ahead of all EU nations and Korea. The report concludes that Japan is a ripened country for growth across a number of product classes, but the enduring winners of regulatory changes and innovative R&D remain hard to pick.
Reference Link: https://biospectrumasia.com/news/50/12865/japan-second-fastest-pharma-growth-in-2019-cphi-report.html
Future generations will face a ticking environmental “time bomb” as the world’s groundwater systems take years to act in response to the present day impact of climate change. More than two billion people rely on it to drink or irrigate crops. It slowly revives through rainfall but a dry climate or draught threatens the available source of water. Population explosion is also a contributing factor. The planet takes time to adjust to the ever-changing planet. Climate change, Heating of the planet is affecting the natural resource.